EGF and diabetic kidney disease: When participants were divided into tertiles corresponding to worsening, stable, or improving biomarker values over time, those who had the least longitudinal decline in EGF over time, as represented by the highest tertile, had a lower risk of DKD progression (adjusted HR 0.57 [0.34, 0.94]) (Table 3 and Figure 2).